Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Coles N Anthony
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   1,005,229    

Indirect Shares

   124,745      
Direct Value   $39,019,319    

Indirect Value

   $5,215,846      
Total Shares   1,129,974      
Total Value   $44,235,164      


Vertex Pharmaceuticals Inc $36,005,802 NPS Pharmaceuticals Inc $0 Laboratory Corp of America $544,165 Regeneron Pharmaceuticals Inc $1,401,177 Kineta Ord Shs $428,425 Cerevel Therapeutics Holdings, Inc. $639,751 Vertex Pharmaceuticals Inc $36,005,802 NPS Pharmaceuticals Inc $0 Laboratory Corp of America $544,165 Regeneron Pharmaceuticals Inc $1,401,177 Kineta Ord Shs $428,425 Cerevel Therapeutics Holdings, Inc. $639,751
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -2.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX SVP, Comm. Ops. 2005-02-03 74,540 2005-02-03 2,076    Premium*  
            NPS Pharmaceuticals Inc NPSP President, COO & Direc... 2008-03-17 220,066 2007-01-31 0    Premium*  
            Onyx Pharmaceuticals Inc ONXX Chairman & CEO, Director 2013-10-01 0 2008-03-31 0    Premium*  
            Laboratory Corp of America LH Director 2013-02-15 2,584 2011-01-03 0    Premium*  
            Crispr Therapeutics Ag CRSP Director 2016-10-24 0 2016-10-24 70,000    Premium*  
            McKesson Corp MCK Director 2020-08-17 0 2018-07-25 0    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 1,393 2019-01-02 0    Premium*  
            Kineta Ord Shs KA Executive Chair, Direc... 2021-02-01 691,008 2021-02-01 52,669    Premium*  
            Cerevel Therapeutics Holdings, I... CERE 2024-06-03 15,638 2022-12-09 0    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
REGN Regeneron Pharmaceuticals... Director   –       •      –    2023-01-03 4 A $0.00 $0 D/D 165 1,258 0 -
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-02-07 4 OE $3.50 $175,000 D/D 50,000 52,704 0 -
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-02-07 4 AS $33.04 $1,656,401 D/D (50,000) 2,704 0 %
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-03-02 4 AS $27.11 $1,274,377 D/D (47,000) 2,704 0 %
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-03-02 4 OE $3.50 $164,500 D/D 47,000 49,704 0 -
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-03-03 4 OE $3.50 $10,500 D/D 3,000 5,704 0 -
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-03-03 4 AS $27.19 $81,570 D/D (3,000) 2,704 0 %
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-04-11 4 OE $3.50 $175,000 D/D 50,000 52,704 0 -
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-04-11 4 AS $25.06 $1,253,130 D/D (50,000) 2,704 0 %
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-05-04 4 OE $3.50 $175,000 D/D 50,000 52,704 0 -
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-05-04 4 AS $31.36 $1,573,434 D/D (50,000) 2,704 0 %
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-06-01 4 AS $32.60 $1,630,070 D/D (50,000) 2,704 0 %
CERE Cerevel Therapeutics Hold... CEO and Chairperson   •       •      –    2023-06-01 4 OE $3.50 $175,000 D/D 50,000 52,704 0 -
CERE Cerevel Therapeutics Hold...   –       •      –    2023-07-11 4 OE $3.50 $175,000 D/D 50,000 52,704 0 -
CERE Cerevel Therapeutics Hold...   –       •      –    2023-07-11 4 AS $30.03 $1,501,340 D/D (50,000) 2,704 0 %
CERE Cerevel Therapeutics Hold...   –       •      –    2023-09-07 4 OE $3.50 $175,000 D/D 50,000 52,704 0 -
CERE Cerevel Therapeutics Hold...   –       •      –    2023-09-07 4 AS $24.07 $1,203,415 D/D (50,000) 2,704 0 %
CERE Cerevel Therapeutics Hold...   –       •      –    2023-11-02 4 OE $3.50 $135,097 D/D 38,599 41,303 0 -
CERE Cerevel Therapeutics Hold...   –       •      –    2023-11-02 4 AS $25.19 $972,239 D/D (38,599) 2,704 0 %
CERE Cerevel Therapeutics Hold...   –       •      –    2023-11-03 4 AS $25.43 $1,561,458 D/D (61,401) 2,704 0 %
CERE Cerevel Therapeutics Hold...   –       •      –    2023-11-03 4 OE $3.50 $214,904 D/D 61,401 64,105 0 -
CERE Cerevel Therapeutics Hold...   –       •      –    2023-11-07 4 OE $3.50 $94,766 D/D 27,076 29,780 0 -
CERE Cerevel Therapeutics Hold...   –       •      –    2023-11-07 4 AS $25.02 $677,555 D/D (27,076) 2,704 0 %
CERE Cerevel Therapeutics Hold...   –       •      –    2023-11-08 4 OE $3.50 $350 D/D 100 2,804 0 -
CERE Cerevel Therapeutics Hold...   –       •      –    2023-11-08 4 AS $25.16 $2,516 D/D (100) 2,704 0 %
  117  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us